Tag Archives: AMRN

Thursday’s Midday Movers: IntelliPharmaCeutics International (IPCI), Sears Holdings (SHLD), Growlife Inc (PHOT), OHR Pharmaceutical (OHRP), Amarin (AMRN)

So far Thursday, October 11, NASDAQ is up 1.67% and the S&P is down -0.5%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; IntelliPharmaCeutics International (NASDAQ:IPCI), Sears Holdings (NASDAQ:SHLD), Growlife Inc (Other OTC:PHOT),

H.C. Wainwright Believes Amarin (NASDAQ: AMRN) Won’t Stop Here

H.C. Wainwright analyst Andrew Fein maintained a Buy rating on Amarin (NASDAQ: AMRN) today and set a price target of $20. The company’s shares closed yesterday at $12.40, close to its 52-week high of $12.47. Fein observed: “Our price target

Analysts Offer Insights on Healthcare Companies: Amarin (NASDAQ: AMRN) and Immutep Limited (Other OTC: IMMP)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Amarin (NASDAQ:AMRN) and Immutep Limited (Other OTC:IMMP) with bullish sentiments. Amarin (AMRN) In a report released today, Louise Chen from Cantor Fitzgerald

Thursday’s Midday Stock Update: Keryx Biopharma (KERX), Amedica (AMDA), Gastar Exploration (GST), Amarin (AMRN), Frontier Communications Corporation (FTR)

So far Thursday, June 28, NASDAQ is up 0.87% and the S&P is up 0.8%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Keryx Biopharma (NASDAQ:KERX), Amedica (NASDAQ:AMDA), Gastar Exploration (NYSE MKT:GST), Amarin

Thursday’s Midday Movers: Keryx Biopharma (KERX), Amedica (AMDA), Gastar Exploration (GST), American Green Inc (ERBB), Amarin (AMRN)

So far Thursday, June 28, NASDAQ is up 0.87% and the S&P is up 0.8%. Here are this morning’s most active stocks: Keryx Biopharma (NASDAQ:KERX), Amedica (NASDAQ:AMDA), Gastar Exploration (NYSE MKT:GST), American Green Inc (Other OTC:ERBB) and Amarin (NASDAQ:AMRN). Keryx

Cantor Fitzgerald Reaffirms Their Buy Rating on Amarin

In a report released today, Louise Chen from Cantor Fitzgerald maintained a Buy rating on Amarin (NASDAQ: AMRN), with a price target of $10. The company’s shares closed yesterday at $3.48. Chen observed: “We reaffirm our OW rating and believe